Cellular uptake of the tat protein from human immunodeficiency virus - PubMed (original) (raw)
Cellular uptake of the tat protein from human immunodeficiency virus
A D Frankel et al. Cell. 1988.
Abstract
While developing an assay to measure the activity of the tat protein from human immunodeficiency virus 1 (HIV-1), we discovered that the purified protein could be taken up by cells growing in tissue culture and subsequently trans-activate the viral promoter. Trans-activation is dramatically increased by a variety of lysosomotrophic agents. For example, trans-activation can be detected at tat concentrations as low as 1 nM in the presence of chloroquine. Experiments using radioactive protein show that tat becomes localized to the nucleus after uptake and suggest that chloroquine protects tat from proteolytic degradation. These results raise the possibility that, under some conditions, tat might act as a viral growth factor to stimulate viral replication in latently infected cells or alter expression of cellular genes.
Similar articles
- Cellular uptake of the tat protein from human immunodeficiency virus.
[No authors listed] [No authors listed] Dis Markers. 1990 Jan-Feb;8(1):33-4. Dis Markers. 1990. PMID: 2178855 No abstract available. - Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication.
Kessler M, Mathews MB. Kessler M, et al. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10018-22. doi: 10.1073/pnas.88.22.10018. Proc Natl Acad Sci U S A. 1991. PMID: 1658792 Free PMC article. - Paracrine activation of the HIV-1 LTR promoter by the viral Tat protein is mechanistically similar to trans-activation within a cell.
Verhoef K, Klein A, Berkhout B. Verhoef K, et al. Virology. 1996 Nov 15;225(2):316-27. doi: 10.1006/viro.1996.0606. Virology. 1996. PMID: 8918918 - Regulation of expression of human immunodeficiency virus.
Pavlakis GN, Felber BK. Pavlakis GN, et al. New Biol. 1990 Jan;2(1):20-31. New Biol. 1990. PMID: 2078551 Review. - Tackling Tat.
Karn J. Karn J. J Mol Biol. 1999 Oct 22;293(2):235-54. doi: 10.1006/jmbi.1999.3060. J Mol Biol. 1999. PMID: 10550206 Review.
Cited by
- Beyond Transduction: Anti-Inflammatory Effects of Cell Penetrating Peptides.
Lopuszynski J, Wang J, Zahid M. Lopuszynski J, et al. Molecules. 2024 Aug 29;29(17):4088. doi: 10.3390/molecules29174088. Molecules. 2024. PMID: 39274936 Free PMC article. Review. - Intercellular Transport of Viral Proteins.
Simon F, Thoma-Kress AK. Simon F, et al. Results Probl Cell Differ. 2024;73:435-474. doi: 10.1007/978-3-031-62036-2_18. Results Probl Cell Differ. 2024. PMID: 39242389 Review. - Plasma membrane damage limits cytoplasmic delivery by conventional cell penetrating peptides.
Polderdijk SGI, Limzerwala JF, Spiess C. Polderdijk SGI, et al. PLoS One. 2024 Sep 3;19(9):e0305848. doi: 10.1371/journal.pone.0305848. eCollection 2024. PLoS One. 2024. PMID: 39226290 Free PMC article. - Structural regression modelling of peptide based drug delivery vectors for targeted anti-cancer therapy.
Christian Y, Redkar AS, Kumar N, Jancy SV, Chandrasekharan A, Retnabai Santhoshkumar T, Ramakrishnan V. Christian Y, et al. Drug Deliv Transl Res. 2024 Aug 8. doi: 10.1007/s13346-024-01674-y. Online ahead of print. Drug Deliv Transl Res. 2024. PMID: 39117921 - Intracellular delivery strategies using membrane-interacting peptides and proteins.
Mai LD, Wimberley SC, Champion JA. Mai LD, et al. Nanoscale. 2024 Aug 22;16(33):15465-15480. doi: 10.1039/d4nr02093f. Nanoscale. 2024. PMID: 39091235 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources